Early diabetes in WKY and SHR produces decrease of the responses to angiotensin II and 5-HT and changes in the NO-GMPc pathway

Clinical and Experimental Hypertension

Volumn 31, Issue 5, 2009, Pages 462-470

  Hong, Enrique ^a   Villafaña, Santiago ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Angiotensin II; Diabetes type I; Hypertension; Serotonin nitric oxide; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN II; CYCLIC GMP; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; SYSTOLIC BLOOD PRESSURE; VASCULAR RING; VASOCONSTRICTION;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; AORTA; CYCLIC GMP; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; MALE; NITRIC OXIDE; NITROPRUSSIDE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SEROTONIN; SIGNAL TRANSDUCTION; STREPTOZOCIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 70849107043     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960902825495     Document Type: Article

References (45)

1. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
2. World Health Report. 2002. http://www.who.int/whr/2002.
3. Perin PC, Maule S, Quadri R. Sympathetic nervous system, diabetes, and hypertension. Clin. Exp. Hypertens 2001;23:45-55.
4. Harrison TR. Principios de medicina interna, 16th ed. New York: McGraw-Hill, 1994, pp. 1175-1190.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
6. Huang F, Villafana S, Hong E. Role of central and sympathetic nervous systems in pressor effect of L-NAME. J Cardiovasc Pharmacol 2003;41:68-72.
7. Brovkovych V, Dobrucki LW, Brovkovych S, Dobrucki I, Do Nascimento CA, Burewicz A, Malinski T. Nitric oxide release from normal and dysfunctional endothelium. J Physiol Pharmacol 1999;50:575-586. (Pubitemid 30022136)
8. Balbatun A, Louka FR, Malinski T. Dynamics of nitric oxide release in the cardiovascular system. Acta Biochim Pol 2003;50:61-68.
9. Brodsky SV, Morrishow AM, Dharia N, Gross SS, Gologorsky MS. Glucose scavenging of nitric oxide. Am J Physiol 2001;280:F480-486.
10. Cheng JB, Shibata S. Vascular relaxation in the spontaneously hypertensive rat. J Cardiovasc Pharmacol 1981;3:1126-1140.
11. Winquist RJ, Bunting PB, Baskin EP, Wallace AA. Decreased endothelium-dependent relaxation in New Zealand genetic hypertensive rats. J Hypertens 1984;2:541-545.
12. McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension: The role of superoxide anion. Hypertension 1994;34:539-545.
13. Thakali KM, Lau Y, Fink GD, Galligan JJ, Chen AF, Watts SW. Mechanisms of hypertension induced by nitric oxide (NO) deficiency: Focus on venous function. J Cardiovasc Pharmacol 2006;47:742-750.
14. Liu MH, Jin HK, Floten HS, Yang Q, Yim AP, Furnary A, Zioncheck TF, Bunting S, He GW. Vascular endothelial growth factor-mediated endothelium-dependent relaxation is blunted in spontaneously hypertensive rats. J Pharmacol Exp Ther 2001;296:473-477.
15. Chatziantoniou C, Arendshorst WJ. Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature. Am J Physiol 1992;262:F124-130.
16. Bell DR. Vascular smooth muscle responses to endothelial autacoids in rats with chronic coarctation hypertension. J Hypertens 1993;11:65-74.
17. Busse R, Fleming I, Hecker M. Signal transduction in endothelium- dependent vasodilatation. Eur Heart J 1993;14:2-9.
18. Taddei S, Mattei P, Virdis A, Sudano I, Ghiadoni L, Salvetti A. Forearm vasodilation in response to acetylcholine is increased by potassium in essential hypertensive patients. J Hypertens Suppl 1993;11:S144-145.
19. Gao YJ, Lee RM. Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. Br J Pharmacol 2001;134:1639-1646.
20. Matz RL, Van Overloop B, Gairard A. Hypotensive effect of endothelin-1 in nitric oxidedeprived, hypertensive pregnant rats. Am J Hypertens 2001;14:585-591.
21. Tesfamariam B, Brown ML, Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 1991;87:1643-1648.
22. Guo Z, Su W, Allen S, Pang H, Daugherty A, Smart E, Gong MC. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 2005;67:723-735.
23. Huang A, Koller A. Endothelin and prostaglandin H2 enhance arteriolar myogenic tone in hypertension. Shear stress-induced release of prostaglandin H(2) in arterioles of hypertensive rats. Hypertension 1997;30:1210-1215.
24. Huang A, Sun D, Koller. Shear stress-induced release of prostaglandin H(2) in arterioles of hypertensive rats. Hypertension 2000;35:925-930.
25. Tesfamariam B, Brown ML, Cohen RA. 15-Hydroxyeicosatetraenoic acid and diabetic endothelial dysfunction in rabbit aorta. J Cardiovasc Pharmacol 1995;25:748-755.
26. Moreau P. Endothelin in hypertension: A role for receptor antagonists? Cardiovasc Res 1998;39:534-542.
27. Kobayashi T, Matsumoto T, Kamata K. The PI3-K/Akt pathway: Roles related to alterations in vasomotor responses in diabetic models. J Smooth Muscle Res 2005;41:283-302.
28. Ramage AG. Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Res Bull 2001;56:425-439.
29. Kawasaki H, Takasaki K. Vasoconstrictor response induced by 5-hydroxytryptamine released from vascular adrenergic nerves by periarterial nerve stimulation. J Pharmacol Exp Ther 1984;229:816-822
30. Ferrario CM. Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An overview. Drugs 1990;39:1-8.
31. Ferrario CM. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst 2006;7:3-14.
32. Matsumoto T, Noguchi E, Kobayashi T, Kamata K. Mechanisms underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats. Free Radic Biol Med 2007;42:993-1007.
33. Kamata K, Hosokawa M, Matsumoto T, Kobayashi T. Acetylcholine-induced vasodilation in the perfused kidney of the streptozotocin-induced diabetic rat: Role of prostacyclin. J Smooth Muscle Res 2006;42:159-170. (Pubitemid 44917599)
34. Ozcelikay AT, Tay A, Dincer D, Meral S, Yildizoglu-Ari N, Altan VM. The effects of chronic L-arginine treatment on vascular responsiveness of streptozotocin-diabetic rats. Gen Pharmacol 1999;33: 299-306. (Pubitemid 29465735)
35. Chang KS, Stevens WC. Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br J Pharmacol 1992;107:983-990.
36. Cheng X, Leung SW, Lim SL, Pang CC. Attenuated arterial and venous constriction in conscious rats with streptozotocin-induced diabetes. Eur J Pharmacol 2003;458:299-304.
37. Pieper GM. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: Importance of disease duration. Diabetologia 1999;42:204-213.
38. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
39. Cheng X, Pang CC. Increased vasoconstriction to noradrenaline by 1400W, inhibitor of iNOS, in rats with streptozotocin-induced diabetes. Eur J Pharmacol 2004;484:263-268.
40. Domenico R. Pharmacology of nitric oxide: Molecular mechanisms and therapeutic strategies. Curr Pharm Des 2004;10:1667-1676.
41. Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, Hase T, Saito I. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens 2007;20:508-513.
42. Miyagawa K, Ohashi M, Yamashita S, Kojima M, Sato K, Ueda R, Dohi Y. Increased oxidative stress impairs endothelial modulation of contractions in arteries from spontaneously hypertensive rats. J Hypertens 2007;25:415-421.
43. Kagota S, Kubota Y, Nejime N, Nakamura K, Kunitomo M, Shinozuka K. Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2007;34:48-54.
44. Vesely DL, Rovere LE, Levey GS. Activation of guanylate cyclase by streptozotocin and 1-methyl- 1-nitrosourea. Cancer Res 1977;37: 28-31.
45. Vesely DL, Levey GS. The effect of streptozotocin analogues on guanylate cyclase activity. Horm Metab Res 1978;10:392-395.